Elite Pharmaceuticals, Inc. Gain (Loss) Related to Litigation Settlement
Elite Pharmaceuticals, Inc. (ELTP) reported Gain (Loss) Related to Litigation Settlement of $1.76 million for the 12-month period ending 2024-03-31, per its 10-K filed 2025-06-30.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2025-06-30
- Elite Pharmaceuticals, Inc. gain (loss) related to litigation settlement for the quarter ending 2024-03-31 was $0.00.
- Elite Pharmaceuticals, Inc. gain (loss) related to litigation settlement for the quarter ending 2023-12-31 was $1.76M.
- Elite Pharmaceuticals, Inc. gain (loss) related to litigation settlement for fiscal 2024 was $1.76M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-30 | $1.76M derived: sum of 2 quarters · filed 2025-06-30 | $1.76M 10-K · filed 2025-06-30 | |
| 2023-12-31 | $1.76M 10-Q · filed 2024-02-14 | $1.76M 10-Q · filed 2025-02-13 |